The global neurostimulation devices market will reach $13bn in 2024 and is estimated to grow at a CAGR of 13% from 2024 to 2029. In 2018, the spinal cord stimulators segment accounted for 45% of the global neurostimulation devices market.
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 166-page report you will receive 102 charts– all unavailable elsewhere.
The 166-page report provides clear detailed insight into the neurostimulation devices market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global Neurostimulation Devices Market from 2019-2029
• Forecast of the Global Neurostimulation Devices market by Product:
• Spinal Cord Stimulators
• Deep Brain Stimulators
• Sacral Nerve Stimulators
• Vagus Nerve Stimulators
• Cortical Stimulators
• Others
Each submarket is further segmented by regional and national market: US, Canada, Germany, France, the UK, Italy, Spain, Rest of Europe, Japan, China, India, Rest of APAC, Latin America, Middle East & Africa
• Forecast of the Global Neurostimulation Devices market by Application:
• Pain Management
• Epilepsy
• Urinary and Fecal Incontinence
• Hearing Loss
• Gastroparesis
• Parkinson’s Disease
• Others
Each submarket is further segmented by regional and national market: US, Canada, Germany, France, the UK, Italy, Spain, Rest of Europe, Japan, China, India, Rest of APAC, Latin America, Middle East & Africa
• This report provides individual revenue forecasts to 2028 for these regional and national markets:
• North America: US, Canada
• Europe: Germany, France, United Kingdom, Italy, Spain and rest of Europe
• Asia-Pacific: Japan, China, India and rest of Asia-Pacific
• RoW: Latin America, Middle East & Africa
• Our study discusses the selected leading companies that are the major players in the neurostimulation devices market:
• Advanced Bionics
• Boston Scientific Corporation
• Cochlear ltd
• Cyberonics
• Medtronic
• Neuronetics Inc
• Nervo Corp.
• Cogentic Medical Inc
• St Jude Medical
• NDI Medical
• Our study discusses the factors that drive and restrain the neurostimulation devices market:
Visiongain’s study is intended for anyone requiring commercial analyses for the neurostimulation devices market. You find data, trends and predictions.
Buy our report today Neurostimulation Devices Market 2019-2029: Spinal Cord Stimulators, Deep Brain Stimulators, Vagus Nerve Stimulators, Sacral Nerve Stimulators, Cortical Stimulators, Epilepsy, Pain Management, Hearing Loss, Incontinence, Gastroparesis, Parkinson’s Disease
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
1. Report Overview
1.1 Why You Should Read This Report
1.2 How This Report Delivers
1.3 Key Questions Answered by This Analytical Report Include:
1.4 Who is This Report for?
1.5 Methodology
1.5.1 Primary Research
1.5.2 Secondary Research
1.5.3 Market Evaluation & Forecasting Methodology
1.6 Frequently Asked Questions (FAQ)
1.7 Associated Visiongain Reports
1.8 About Visiongain
2. Introduction to the Neurostimulation Devices Market
2.1 Classification of Neurostimulation Devices
2.2 What are Neurostimulation Devices?
2.3 Regulation of Medical Devices?
2.3.1 The US Approval and Regulation System
2.3.2 The EU Approval and Regulation System
2.3.3 China Approval and Regulation System
2.3.4 Japan Approval and Regulation System
2.3.5 India Approval and Regulation System
3. Neurostimulation Devices Market: Drivers & Restraints
3.1 Driving Factors
3.1.1 Growing prevalence of neurological disorders
3.1.2 Increasing Growth of Aging Population
3.1.3 Changing Lifestyle and growing obesity
3.1.4 Various opportunities from emerging markets
3.2 Market Restraints
3.2.1 Shortage of neurologists to treat an increasing number of neurologic patients
3.2.2 Uncertain outcomes of changing healthcare policies
3.2.3 Imposition of the medical device excise tax in the U.S.
3.2.4 Poor primary healthcare infrastructure and lack of healthcare insurance in developing countries
4. Global Neurostimulation Devices Market by Product, 2019-2029
4.1 Spinal Cord Stimulators Market Forecast 2019-2029
4.2 Deep Brain Stimulators Market Forecast 2019-2029
4.3 Vagus Nerve Stimulators Market Forecast 2019-2029
4.4 Sacral Nerve Stimulators: Market Forecast 2019-2029
4.5 Cortical Stimulators Market Forecast 2019-2029
4.6 Other Neurostimulation Devices Market Forecast 2019-2029
5. Global Neurostimulation Devices Market by Application, 2019-2029
5.1 Epilepsy Neurostimulation Devices Market Forecast 2019-2029
5.2 Pain Management Neurostimulation Devices Market Forecast 2019-2029
5.3 Hearing Loss Neurostimulation Devices Market Forecast 2019-2029
5.4 Urinary and Faecal Incontinence Neurostimulation Devices Market Forecast 2019-2029
5.5 Gastroparesis Neurostimulation Devices Market Forecast 2019-2029
5.6 Parkinson’s Disease Neurostimulation Devices Market Forecast 2019-2029
5.7 Others Application Market Forecast 2019-2029
6. Global Neurostimulation Devices Market by Region, 2019-2029
6.1 Introduction
6.2 Regional Breakdown of the Global Neurostimulation Devices Market
6.3 How will Regional Market Shares Change to 2029?
6.4 North America Neurostimulation Devices Market 2019-2029
6.4.1 U.S. Neurostimulation Devices Market Forecast 2019-2029
6.4.2 Canada Neurostimulation Devices Market Forecast 2019-2029
6.5 Europe Neurostimulation Devices Market Forecast 2019-2029
6.5.1 Germany Neurostimulation Devices Market Forecast 2019-2029
6.5.2 France Neurostimulation Devices Market Forecast 2019-2029
6.5.3 UK Neurostimulation Devices Market Forecast 2019-2029
6.5.4 Italy Neurostimulation Devices Market Forecast 2019-2029
6.5.5 Spain Neurostimulation Devices Market Forecast 2019-2029
6.5.6 Rest of Europe (RoE)
6.6 Asia-Pacific Neurostimulation Devices Market Forecast 2019-2029
6.6.1 Japan Neurostimulation Devices Market Forecast 2019-2029
6.6.2 China Neurostimulation Devices Market Forecast 2019-2029
6.6.3 India Neurostimulation Devices Market Forecast 2019-2029
6.6.4 Rest of Asia-pacific Neurostimulation Devices Market Forecast 2019-2029
6.7 Rest of the World Neurostimulation Devices Market Forecast 2019-2029
6.7.1 Latin America Neurostimulation Devices Market Forecast 2019-2029
6.7.2 Middle East & Africa Neurostimulation Devices Market Forecast 2019-2029
7. Leading Companies in the Neurostimulation Devices Market
7.1 Advanced Bionics, LLC
7.1.1 Advanced Bionics, LLC: Overview
7.1.2 Advanced Bionics, LLC: Financials
7.1.3 Advanced Biologics, LLC: Product Portfolio
7.1.4 Advanced Biologics, LLC: Developments
7.2 Boston Scientific Corporation
7.2.1 Boston Scientific: Overview
7.2.2 Boston Scientific: Financials
7.2.3 Boston Scientific: Product portfolio
7.2.4 Boston Scientific: Developments
7.3 Cochlear Ltd.
7.3.1 Cochlear Ltd.: Overview
7.3.2 Cochlear Ltd.: Financials
7.3.3 Cochlear Ltd.: Product Portfolio
7.3.4 Cochlear Ltd.: Developments
7.4 Cyberonics
7.4.1 Cyberonics: Overview
7.4.2 Cyberonics: Financials
7.4.3 Cyberonics: Products Portfolio
7.4.4 Cyberonics: Developments
7.5 Medtronic plc
7.5.1 Medtronic plc: Overview
7.5.2 Medtronic plc: Financials
7.5.3 Medtronic plc: Product Portfolio
7.5.4 Medtronic plc: Developments
7.6 Neuronetics, Inc.
7.6.1 Neuronetics, Inc: Overview
7.6.2 Neuronetics, Inc: Financials
7.6.3 Neuronetics, Inc: Product Portfolio
7.6.4 Developments
7.7 Nevro Corp.
7.7.1 Nevro Corp.: Overview
7.7.2 Nevro Corp.: Financials
7.7.3 Nevro Corp.: Product Portfolio
7.7.4 Nevro Corp.: Developments
7.8 Cogentix Medical Inc
7.8.1 Cogentix Medical Inc: Overview
7.8.2 Cogentix Medical Inc: Financials
7.8.3 Cogentix Medical Inc: Product Portfolio
7.8.4 Cogentix Medical Inc: Developments
7.9 St. Jude Medical
7.9.1 St. Jude Medical: Overview
7.9.2 St. Jude Medical: Financials
7.9.3 St. Jude Medical: Product Portfolio
7.9.4 St. Jude Medical: Developments
7.10 NDI Medical, LLC.
7.10.1 NDI Medical, LLC.: Overview
7.10.2 NDI Medical, LLC.: Product portfolio
7.10.3 NDI Medical, LLC.: Developments
8. The Global Neurostimulation Devices Market, Competitive Landscape
8.1 New Product Launches
8.2 Acquisitions, Collaborations, and Partnerships
8.3 Other Developments
9. Conclusions
9.1 Top Neurostimulation Devices Market
9.2 Top Neurostimulation Devices Applications Market
9.3 Top Nations Neurostimulation in the Devices Market
Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain report evaluation form
List of Tables
Table 4.1 Neurostimulation Devices Submarkets by Product: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 4.2 Spinal Cord Stimulators Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 4.3 Deep Brain Stimulators by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 4.4 Vagus Nerve Stimulators Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 4.5 Sacral Nerve Stimulators Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 4.6 Cortical Stimulators Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 4.7 Other Neurostimulation devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 5.1 Neurostimulation devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 5.2 Epilepsy Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 5.3 Pain Management Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 5.4 Hearing Loss Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 5.5 Urinary and Faecal Incontinence Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 5.6 Gastroparesis Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 5.7 Parkinson’s Disease Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 5.8 Other Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 6.1 Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 6.2 North America Neurostimulation Devices Markets by Country: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 6.3 North America Neurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 6.4 North America Neurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 6.5 Europe Neurostimulation Devices Markets by Country: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 6.6 Europe Neurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 6.7 Europe Neurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 6.8 Asia-Pacific Neurostimulation Devices Markets by Country: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 6.9 Asia-Pacific Neurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 6.10 Asia-Pacific Neurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 6.11 Rest of the World Neurostimulation Devices Markets by Region: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 6.12 Rest of the World Neurostimulation Devices Markets by Product: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 6.13 Rest of the World Neurostimulation Devices Markets by Application: Forecast ($m, AGR%, CAGR%), 2019-2029
Table 7.1 Advanced Bionics Product Portfolio
Table 7.2 Advanced Bionics: Developments
Table 7.3 Boston Scientific Corporation: Product Portfolio
Table 7.4 Boston Scientific Corporation: Developments
Table 7.5 Cochlear Ltd.: Product Portfolio
Table 7.6 Cochlear Ltd.: Developments
Table 7.7 Cyberonics.: Product Portfolio
Table 7.8 Cyberonics: Developments
Table 7.9 Medtronic plc: Product Portfolio
Table 7.10 Medtronic plc: Developments
Table 7.11 Neuronetics: Product Portfolio
Table 7.12 Neuronetics: Developments
Table 7.13 Nevro Corp: Product Portfolio
Table 7.14 Nevro Corp: Developments
Table 7.15 Cogentix Medical: Product Portfolio
Table 7.16 Cogentix Medical: Developments
Table 7.17 St. Jude Medical: Product Portfolio
Table 7.18 St. Jude Medical: Developments
Table 7.19 NDI Medical: Product Portfolio
Table 7.20 NDI Medical: Developments
Table 8.1 New Product Launches
Table 8.2 Acquisitions, Collaborations, and Partnerships
Table 8.3 Other Developments
List of Figures
Figure 2.1 Neurostimulation Devices Market Segmentation
Figure 2.2 Stages of regulatory control
Figure 3.1 Neurostimulation Devices Market: Drivers and Restraints, 2019-2029
Figure 3.2 Share of geriatric population, by region, 2010-2020
Figure 4.1 Neurostimulation Devices Submarkets by Product: Forecast Revenue ($m) and CAGR (%) 2019-2029
Figure 4.2 Spinal Cord Stimulators Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029
Figure 4.3 Deep Brain Stimulators Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029
Figure 4.4 Vagus Nerve Stimulators Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029
Figure 4.5 Sacral Nerve Stimulators Devices Markets by Region: Forecast ($m), 2019-2029
Figure 4.6 Cortical Stimulators by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029
Figure 4.7 Other Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029
Figure 5.1 Neurostimulation Devices Markets by Application: Forecast Revenue ($m) and CAGR (%) 2019-2029
Figure 5.2 Epilepsy Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029
Figure 5.3 Pain Management Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029
Figure 5.4 Hearing Loss Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029
Figure 5.5 Urinary and Faecal Incontinence Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029
Figure 5.6 Gastroparesis Neurostimulation devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029
Figure 5.7 Parkinson’s Disease Neurostimulation Devices Markets by Region: Forecast Revenue ($m) and CAGR (%) 2019-2029
Figure 5.8 Other Neurostimulation Devices Markets by Region: Forecast ($m), 2019-2029
Figure 6.1 Neurostimulation Devices Markets by Region: Share (%), 2018
Figure 6.2 North America Neurostimulation Devices Markets by Country: Share (%), 2018
Figure 6.3 U.S. Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
Figure 6.4 Increasing Prevalence Rate in Canada by Chronic Diseases, 2001-2039
Figure 6.5 Canada Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
Figure 6.6 Europe Neurostimulation Devices Markets by Country: Share (%), 2018
Figure 6.7 Change in population structure in Germany, 1995-2015
Figure 6.8 Germany Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
Figure 6.9 France Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
Figure 6.10 U.K. Population estimates and projections, 2010-2039
Figure 6.11 U.K. Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
Figure 6.12 Italy Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
Figure 6.13 Spain Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
Figure 6.14 Asia-Pacific Neurostimulation Devices Markets by Country (%), 2018
Figure 6.15 Japan Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
Figure 6.16 Share of Aging population in total Chinese population, 2011-2016 (%)
Figure 6.17 China Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
Figure 6.18 India Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
Figure 6.19 Rest of the World Neurostimulation Devices Markets by Region (%), 2018
Figure 6.20 Latin America Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
Figure 6.21 Middle East and Africa Revenue Neurostimulation Devices Revenue ($m) and AGR (%) 2019-2029
Figure 7.1 Advanced Bionics: Historical Revenues ($m), 2015-2017
Figure 7.2 Boston Scientific Corporation: Historical Revenues ($m), 2015-2017
Figure 7.3 Cochlear: Historical Revenues ($m), 2015-2017
Figure 7.4 Cyberonics: Historical Revenues ($m), 2015-2017
Figure 7.5 Medtronic plc: Recent Financials, 2015-2017
Figure 7.6 Nevro Corp: Recent Financials, 2015-2017
Figure 7.7 Cogentix Medical, Inc.: Recent Financials, 2016-2017
Figure 7.8 St. Jude Medical: Recent Financials, 2015-2017
Figure 9.1 Top Neurostimulation Devices Market
Figure 9.2 Top Neurostimulation Devices Applications
Figure 9.3 Top Nations in the Neurostimulation Devices Market
Abbott Laboratories
Advanced Bionics LLC
Alliance BiomedicaPvt Ltd.
Axonics Modulation Technologies
Blackrock
Boston Scientific Corporation
Cameron Health
Cardiac Pacemakers, Inc.
Cochlear AG
Cochlear Holdings NV
Cochlear Ltd.
Cochlear Verwaltungs GmbH
Codman & Shurtleff
Cogentix Medical Inc.
Cyberonics, Inc.
ElectroCore
Enteromedics
EP Technologies
Functional Neuromodulation
Greatbatch
Guidant
IntraPace
LABORIE Medical Technologies
LivaNova
Medtronic
Microtransponder
Morris K. Udall Centers of Excellence for Parkinsons Disease
Neuronetics, Inc.
Neuropace
Neurosigma
Nevro
Nevro Corp.
Otologics
Sonova Holding AG
St. Jude Medical
Stimwave
Symetis SA
Thoratec
Uroplasty Inc.
Zynex
List of Organisations
American Academy of Neurology
Centers for Disease Control and Prevention (CDC)
CFDA
Chinese Food & Drug Administration (CFDA)
Epilepsy Foundation
European Commission
Federal Interagency Forum on Aging-Related Statistics
Food & Drug Administration (US)
Insurance Regulatory and Development Authority (IRDA)
International Labour Organization (ILO)
Ministry of Health, Labor and Welfare (MHLW)
National Health Service (UK)
National Institute of Population and Social Security Research
National Institutes of Health (NIH)
Parkinson’s Disease Foundation
World Health Organisation (WHO)
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
